Description
Erlonat (Erlotinib Hydrochloride) is a prescription medication used for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It contains the active ingredient Erlotinib Hydrochloride.
Uses:
Erlonat is used to treat advanced or metastatic non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It works by inhibiting the activity of the epidermal growth factor receptor (EGFR), which is a protein that promotes cell growth and division. By inhibiting this protein, Erlonat prevents the growth and spread of cancer cells.
HOW TO USE:
Erlonat tablets should be taken orally, with or without food, as directed by the doctor. Patients should never exceed the recommended dosage. The dosage and duration of treatment will be determined by the doctor based on the patient’s medical history and response to treatment.
Storage Conditions:
Erlonat tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Keep it away from direct sunlight, heat, and moisture. Ensure that the medication is kept out of reach of children and pets.
Mechanism of action:
Erlonat contains the active ingredient Erlotinib Hydrochloride, which works by inhibiting the activity of the epidermal growth factor receptor (EGFR). This receptor is present on the surface of cancer cells and plays a role in their growth and survival. By inhibiting this receptor, Erlonat prevents the cancer cells from growing and dividing, which stops the spread of the cancer.
Precautions:
– Erlonat should only be used under medical supervision and by individuals who have been diagnosed with advanced or metastatic non-small cell lung cancer (NSCLC).
– Patients with liver or kidney problems, high cholesterol levels, diabetes, or other medical conditions should inform their doctor before using Erlonat, as these conditions may affect the safety or effectiveness of the medication.
– Erlonat may interact with other medications and affect their effectiveness or increase the risk of side effects. Patients should inform their doctor if they are taking any prescription or over-the-counter medications, vitamins, or herbal supplements.
Contraindications:
Erlonat is contraindicated for patients who:
– Have an allergy to Erlotinib Hydrochloride or any of its ingredients
– Are pregnant or breastfeeding
– Have severe liver or kidney problems
Drug Interactions:
Erlonat may interact with other medications and affect their effectiveness or increase the risk of side effects. Patients should inform their doctor if they are taking any prescription or over-the-counter medications, vitamins, or herbal supplements.
Overdose:
In the event of an overdose, patients should seek immediate medical attention. Symptoms of an overdose may include severe skin rash, diarrhea, and abdominal pain.
Side Effects:
Erlonat may cause side effects, which may vary in severity and depend on the dosage and duration of treatment. Common side effects include:
– Skin rash
– Fatigue
– Loss of appetite
– Nausea
– Diarrhea
Less common but serious side effects may include:
– Liver problems
– Lung problems
– Kidney problems
Patients should inform their doctor immediately if they experience any serious or persistent side effects.
Reviews
There are no reviews yet.